Janney Montgomery Scott
AIMT

Janney Montgomery Scott’s Aimmune Therapeutics AIMT Stock Holding History

Janney Montgomery Scott’s Portfolio AIMT Stock Details AIMT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-9,349
Closed -$322K – 2310
2020
Q3 		$322K Sell
9,349
-14,640
-61% -$312K ﹤0.01% 1662
2020
Q2 		$401K Sell
23,989
-604
-2% -$10.3K ﹤0.01% 1475
2020
Q1 		$355K Buy
24,593
+2,826
+13% +$72.2K ﹤0.01% 1402
2019
Q4 		$729K Sell
21,767
-4,277
-16% -$120K ﹤0.01% 1243
2019
Q3 		$545K Buy
26,044
+11,824
+83% +$241K ﹤0.01% 1338
2019
Q2 		$296K Buy
+14,220
New +$293K ﹤0.01% 1707
2018
Q4 		– Sell
-9,720
Closed -$265K – 2109
2018
Q3 		$265K Sell
9,720
-5,000
-34% -$141K ﹤0.01% 1782
2018
Q2 		$396K Buy
14,720
+3,200
+28% +$97.9K ﹤0.01% 1515
2018
Q1 		$367K Buy
11,520
+4,500
+64% +$158K ﹤0.01% 1505
2017
Q4 		$265K Buy
+7,020
New +$227K ﹤0.01% 1654

Janney Montgomery Scott's AIMT Position: Q4 2020 in Review

Janney Montgomery Scott sold out of Aimmune Therapeutics (AIMT) in Q4 2020, closing a stake of 9,349 shares — an estimated $322K sold.

Janney Montgomery Scott first reported a position in AIMT in Q4 2017 and held it in 10 quarters. The position peaked at $729K in Q4 2019. 0 funds tracked by Wall St. Rank hold AIMT as of Q4 2020.

  • Janney Montgomery Scott reported no remaining Aimmune Therapeutics position as of Q4 2020 after selling out during the quarter.
  • Janney Montgomery Scott sold 9,349 Aimmune Therapeutics shares in Q4 2020, an estimated $322K.
  • Janney Montgomery Scott first reported a position in Aimmune Therapeutics in Q4 2017 and held it in 10 quarters.
  • Janney Montgomery Scott's Aimmune Therapeutics position peaked at $729K in Q4 2019.
  • 0 funds tracked by Wall St. Rank held Aimmune Therapeutics as of Q4 2020.

Based on Janney Montgomery Scott's 13F filing for Q4 2020, filed 25 Jan 2021.